Advertisement
UK markets close in 1 hour 34 minutes
  • FTSE 100

    8,040.64
    +16.77 (+0.21%)
     
  • FTSE 250

    19,692.50
    +93.11 (+0.48%)
     
  • AIM

    753.46
    +4.28 (+0.57%)
     
  • GBP/EUR

    1.1616
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.2445
    +0.0095 (+0.77%)
     
  • Bitcoin GBP

    53,518.16
    +353.27 (+0.66%)
     
  • CMC Crypto 200

    1,424.70
    +9.94 (+0.70%)
     
  • S&P 500

    5,049.88
    +39.28 (+0.78%)
     
  • DOW

    38,425.12
    +185.14 (+0.48%)
     
  • CRUDE OIL

    81.53
    -0.37 (-0.45%)
     
  • GOLD FUTURES

    2,336.20
    -10.20 (-0.43%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,066.91
    +206.11 (+1.15%)
     
  • CAC 40

    8,086.20
    +45.84 (+0.57%)
     

BUZZ-Alibaba: in the shadow of the 800-pound-plus IPO

** Alibaba's mammoth roadshow has eclipsed a full slate of deals on the docket to price in the next few weeks.

** That includes the $3.4 bln Citizens Financial IPO, one of the largest new listings of the year. Citizens (NYSE: CIA - news) is being spun out of RBS (LSE: RBS.L - news) & is slated to price Sept. 23.

** Elsewhere in IPO land, Travelport Worldwide, the UK-based travel services company, launched its IPO last week.

** A handful of smaller-sized pharmaceutical/biotech IPOs will also clamor for investors' attention this week. However, last week's inauspicious pricing and performance of Affirmed Therapeutics will likely compel issuers to accept lower valuations in order to go public.

ADVERTISEMENT

** For now Alibaba is hogging the headlines. Robust investor demand suggests a good chance of an upsized offering that could potentially make it the largest IPO in history.

** Company's current filing is 320 million shares at a price range of $60-$66, a $21.2 billion assuming a pricing at the top end of the range.

** Even (Taiwan OTC: 6436.TWO - news) with all eyes on Alibaba and the Fed this week, ECM desks likely to stay busy to make the most of stocks near record highs and investors on the hunt for fresh ideas. (RM (LSE: RM.L - news) : lance.tupper.thomsonreuters.com@reuters.net)